Eran Leitersdorf
Eran Leitersdorf
Professor of Medicine Hebrew University Hadassah Medical School
Dirección de correo verificada de
Citado por
Citado por
Mechanism of action of fibrates on lipid and lipoprotein metabolism
B Staels, J Dallongeville, J Auwerx, K Schoonjans, E Leitersdorf, ...
Circulation 98 (19), 2088-2093, 1998
Effects of dalcetrapib in patients with a recent acute coronary syndrome
GG Schwartz, AG Olsson, M Abt, CM Ballantyne, PJ Barter, J Brumm, ...
New England Journal of Medicine 367 (22), 2089-2099, 2012
Atherosclerosis in the apolipoprotein E–deficient mouse: a decade of progress
KS Meir, E Leitersdorf
Arteriosclerosis, thrombosis, and vascular biology 24 (6), 1006-1014, 2004
Risk for myopathy with statin therapy in high-risk patients
CM Ballantyne, A Corsini, MH Davidson, H Holdaas, TA Jacobson, ...
Archives of internal medicine 163 (5), 553-564, 2003
Common low-density lipoprotein receptor mutations in the French Canadian population.
E Leitersdorf, EJ Tobin, J Davignon, HH Hobbs
The Journal of clinical investigation 85 (4), 1014-1023, 1990
Consensus for the use of fibrates in the treatment of dyslipoproteinemia and coronary heart disease. Fibrate Consensus Group.
JC Fruchart, HB Brewer Jr, E Leitersdorf
The American journal of cardiology 81 (7), 912-917, 1998
Elimination of cholesterol in macrophages and endothelial cells by the sterol 27-hydroxylase mechanism comparison with high density lipoprotein-mediated reverse cholesterol …
A Babiker, O Andersson, E Lund, RJ Xiu, S Deeb, A Reshef, E Leitersdorf, ...
Journal of Biological Chemistry 272 (42), 26253-26261, 1997
Markedly reduced bile acid synthesis but maintained levels of cholesterol and vitamin D metabolites in mice with disrupted sterol 27-hydroxylase gene
H Rosen, A Reshef, N Maeda, A Lippoldt, S Shpizen, L Triger, ...
Journal of Biological Chemistry 273 (24), 14805-14812, 1998
Possible association between diabetes and bisphosphonate-related jaw osteonecrosis
M Khamaisi, E Regev, N Yarom, B Avni, E Leitersdorf, I Raz, S Elad
The Journal of Clinical Endocrinology & Metabolism 92 (3), 1172-1175, 2007
Two common low density lipoprotein receptor gene mutations cause familial hypercholesterolemia in Afrikaners.
E Leitersdorf, DR Van der Westhuyzen, GA Coetzee, HH Hobbs
The Journal of clinical investigation 84 (3), 954-961, 1989
Identification of bile acid precursors as endogenous ligands for the nuclear xenobiotic pregnane X receptor
B Goodwin, KC Gauthier, M Umetani, MA Watson, MI Lochansky, ...
Proceedings of the National Academy of Sciences 100 (1), 223-228, 2003
Rationale and design of the dal-OUTCOMES trial: efficacy and safety of dalcetrapib in patients with recent acute coronary syndrome
GG Schwartz, AG Olsson, CM Ballantyne, PJ Barter, IM Holme, D Kallend, ...
American heart journal 158 (6), 896-901. e3, 2009
Disruption of the sterol 27-hydroxylase gene in mice results in hepatomegaly and hypertriglyceridemia reversal by cholic acid feeding
JJ Repa, EG Lund, JD Horton, E Leitersdorf, DW Russell, JM Dietschy, ...
Journal of Biological Chemistry 275 (50), 39685-39692, 2000
A truncated human peroxisome proliferator-activated receptor α splice variant with dominant negative activity
P Gervois, IP Torra, G Chinetti, T Grötzinger, G Dubois, JC Fruchart, ...
Molecular Endocrinology 13 (9), 1535-1549, 1999
Frameshift and splice-junction mutations in the sterol 27-hydroxylase gene cause cerebrotendinous xanthomatosis in Jews or Moroccan origin.
E Leitersdorf, A Reshef, V Meiner, R Levitzki, SP Schwartz, EJ Dann, ...
The Journal of clinical investigation 91 (6), 2488-2496, 1993
Platelet factor 4 enhances the binding of oxidized low-density lipoprotein to vascular wall cells
T Nassar, BS Sachais, S Akkawi, MA Kowalska, K Bdeir, E Leitersdorf, ...
Journal of Biological Chemistry 278 (8), 6187-6193, 2003
Evidence for a dominant gene that suppresses hypercholesterolemia in a family with defective low density lipoprotein receptors.
HH Hobbs, E Leitersdorf, CC Leffert, DR Cryer, MS Brown, JL Goldstein
The Journal of clinical investigation 84 (2), 656-664, 1989
Refinement of variant selection for the LDL cholesterol genetic risk score in the diagnosis of the polygenic form of clinical familial hypercholesterolemia and replication in …
M Futema, S Shah, JA Cooper, KW Li, RA Whittall, M Sharifi, O Goldberg, ...
Clinical chemistry 61 (1), 231-238, 2015
Alcohol dehydrogenase polymorphisms influence alcohol‐elimination rates in a male Jewish population
YD Neumark, Y Friedlander, R Durst, E Leitersdorf, D Jaffe, ...
Alcoholism: Clinical and Experimental Research 28 (1), 10-14, 2004
Effects of initiating moderate alcohol intake on cardiometabolic risk in adults with type 2 diabetes: a 2-year randomized, controlled trial
Y Gepner, R Golan, I Harman-Boehm, Y Henkin, D Schwarzfuchs, I Shelef, ...
Annals of internal medicine 163 (8), 569-579, 2015
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20